Skip to main content
LobbyMap

Boehringer Ingelheim

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
50/100
Moderate Influence
$5.3M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
1
Revolving Door

Boehringer Ingelheim reported $5.3 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of the Treasury
Federal Energy Regulatory Commission
Dept of Justice
Dept of the Interior
Federal Aviation Administration
Environmental Protection Agency
U.S. House of Representatives

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecCapitol Counsel
HCRPHAGOV+1
1$324K
2024 Jul-SepSummit Strategies Government Affairs
MEDPHA
3$341K
2024 Apr-JunS-3 Group
MEDGOV
1$359K
2024 Jan-MarInvariant LLC
PHAHCRGOV
3$269K
2023 Oct-DecArnold & Porter
MEDHCRPHA+1
4$301K
2023 Jul-SepHogan Lovells
MEDPHA
4$248K
2023 Apr-JunWilliams & Jensen
GOVMED
1$331K
2023 Jan-MarStewart & Stewart
GOVPHA
3$226K

Boehringer Ingelheim Lobbying FAQ

Boehringer Ingelheim has spent $5.3M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Boehringer Ingelheim lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Boehringer Ingelheim has an Influence Score of 50/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Boehringer Ingelheim employs 4 registered lobbyists, of whom 1 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Boehringer Ingelheim has contacted 7 government entities as part of their lobbying activities, including Dept of the Treasury, Federal Energy Regulatory Commission, Dept of Justice.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.